Schering-Plough

Parvovirus Vaccine

MODIFIED LIVE VIRUS

For veterinary use in dogs only

PRODUCT DESCRIPTION:

Galaxy* Pv vaccine is a modified live virus vaccine containing a CPV Type 2b strain for the vaccination of healthy dogs as an aid in the prevention of disease caused by canine parvovirus.

DOSAGE AND ADMINISTRATION:

Inject one dose (1 mL) subcutaneously or intramuscularly. The initial dose may be given at 6 weeks of age or older. Repeat at 2 to 4 week intervals until the dog is 12 weeks of age. Annual revaccination with one dose is recommended. Use entire contents immediately.

PRECAUTIONS:

Store at 2°-7°C.

Do not freeze.

Do not mix with other vaccines.

Use new, non-chemically sterilized needles and syringes.

Burn vaccine container and all unused contents.

WARNINGS:

Contains gentamicin as a preservative.

Vaccinate only healthy, non-parasitized dogs.

Do not vaccinate pregnant bitches.

The use of a biological product may produce anaphylaxis and/or other inflammatory immune-mediated hypersensitivity reactions. Antidote: Epinephrine, corticosteroids, and antihistamines may all be indicated depending on the nature and severity of the reaction.

The age at which maternal antibody for canine parvovirus no longer interferes with the development of active immunity varies according to the bitch's titer and quantity of colostral antibodies absorbed by the puppy.

U.S. Veterinary License No. 165A

Schering-Plough Animal Health Corporation, Omaha, NE 68103 USA

1 800 224-5318 (USA)

1 888 306-0069 (Canada)

© Copyright 1999, 2001, 2003, 2006, Schering-Plough Animal Health Corp.

All rights reserved.

* Reg. U.S. PAT & TM OFFICE Trademark

NAC No.: 10470873